Skip to main content
. 2019 Jan 17;8(2):e010107. doi: 10.1161/JAHA.118.010107

Figure 1.

Figure 1

Impact of left ventricular hypertrophy (LVH) on the association between baseline biomarkers and stroke or systemic embolism (SEE), all‐cause mortality, and major bleeding outcomes. GDF‐15 indicates growth differentiation factor‐15; HR, hazard ratio; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide.